Biological markers increase clinical trial success rate of new breast cancer drugs

Using biological markers—genetic characteristics that are associated with some patients with breast cancer—can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

Read Medical Xpress Article

Read Science Daily Article